Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
April 2026 – November 2026 · 4 captures · latest observed messagingFDA Grants FAST TRACK Designation for AGT's HIV Cure Project (read about AGT103-T)
American Gene Technologies™ (AGT) is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications.
17 April 2026 · FDA Grants FAST TRACK Designation for AGT's HIV Cure Project (read about AGT103-T)archived page
8 July 2026 · FDA Grants FAST TRACK Designation for AGT's HIV Cure Project (read about AGT103-T)archived page
30 August 2026 · FDA Grants FAST TRACK Designation for AGT's HIV Cure Project (read about AGT103-T)archived page
4 November 2026 · FDA Grants FAST TRACK Designation for AGT's HIV Cure Project (read about AGT103-T)current websiteHistorical capture not publicly available
Seen January 2024 · 1 captureAddimmune Launched with the Sole Purpose to Cure HIV
American Gene Technologies™ (AGT) is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications.